Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Kitov Announces License Agreement for KIT-302 in South Korea
Thursday, March 09, 2017Kitov Pharmaceuticals Holdings Ltd an innovative biopharmaceutical company announced today that the Company has signed a definitive License Agreement for its lead product candidate KIT which was developed to simultaneously treat pain caused by osteoa...
Glenmark Pharmaceuticals Receives FDA Clearance of IND for GSP 304
Wednesday, March 08, 2017Glenmark Pharmaceuticals a global pharmaceutical company announced that the US Food and Drug Administration FDA cleared the Companys Investigational New Drug IND application to begin a Phase study of GSP tiotropium bromide for administration by neb...
Kasten, Inc. Completes Merger With Dakota Life Sciences
Wednesday, March 08, 2017Kasten Inc announced that it has completed a merger with Thru Pharma LLC dba DAKOTA Life Sciences Upon review of Dakota during the phases of the JV setup the Board of Directors and Members of Kasten and Dakota determined it was in the best interests...
BeiGene and Guangzhou Development District Establish Joint Venture to Build Biologics Manufacturing Facility
Wednesday, March 08, 2017BeiGene Ltd and Guangzhou Development District GDD announced that BeiGene Hong Kong Co Ltd BeiGene HK a wholly owned subsidiary of BeiGene Ltd and GDD and its affiliate Guangzhou GET Technology Development Co Ltd GET have entered into a definitive ag...
Exelixis' Cabozantinib Granted Orphan Drug Designation for the Treatment of Hepatocellular Carcinoma
Tuesday, March 07, 2017Exelixis Inc announced that the US Food Drug Administration FDA has granted orphan drug designation to cabozantinib for the treatment of hepatocellular carcinoma HCC This information was posted to FDAs website on March and can be accessed here A p...
NuvOx Pharma and the University of Arkansas Initiate Phase Ib/II Clinical Trial in Stroke
Tuesday, March 07, 2017NuvOx Pharma announces that the first patients have been dosed in a Phase IbII clinical trial for NVX an oxygen therapeutic being developed for acute ischemic stroke The trial is being performed at the University of Arkansas for Medical Sciences in L...
Vernalis Plc and Servier Enter into a New Drug Discovery Collaboration
Tuesday, March 07, 2017Vernalis plc and Servier are pleased to announce that they reinforce their partnership by entering into a new twoyear oncology drug discovery collaboration on an undisclosed target This agreement extends the existing successful collaborations betw...
Concert Pharmaceuticals Presents CTP-543 Phase 1 Results at American Academy of Dermatology Annual Meeting
Monday, March 06, 2017Concert Pharmaceuticals Inc announced that the results from the Companys Phase single and multiple ascending dose trial evaluating CTP in healthy volunteers were presented in a poster session at the American Academy of Dermatologys Annual Meeting in...
Sanofi, Regeneron say latest Dupixent eczema drug tests positive
Monday, March 06, 2017Drugmakers Sanofi and Regeneron said on Saturday results from a oneyear test of their Dupixent product aimed at adults with eczema or moderatetosevere atopic dermatitis AD had been positive In the CHRONOS study Dupixent used with topical corticost...
Cardiome Announces Commercial Launch of Xydalba™ (dalbavancin) in France
Saturday, March 04, 2017Cardiome Pharma Corp announced that it received authorization from the French Transparency Pricing Commission to begin selling XYDALBA in France and that it has subsequently launched XYDALBA in France The European Medicines Agency EMA approved XYDALB...
